gedeon richter plc european multinational pharmaceutical biotechnology company headquartered budapest largest pharmaceutical company central eastern europe expanding direct presence western europe china northern america latin america richter largest rd unit central eastern europe operations gedeon richter plc primary listing budapest stock exchange constituent bux index market capitalisation approximately billion third largest companies primary listing budapest stock exchange secondary listings luxembourg stock company sells products central nervous system women health cardiovascular therapeutic areas among others richter also active biosimilar product company established budapest gedeon richter pharmacist pharmacist gedeon richter founded company first received license industrially produce initially smallscale pharmaceutical production took place arany sas golden eagle pharmacy still operates today time pharmaceutical production industrial scale required heavy investments largescale pharmaceutical manufacturing activities considered extremely capitalintensive operations initially laboratory processed extracts organs animals produced organotherapeutic drugs plant built kőbánya suburb budapest first pharmaceutical manufacturing plant regarded outstanding technological achievement day compliance established international trends pharmaceutical industry days company produced herbal drugs processed extracts plants manufactured synthetic products later date company became highly recognized manufacturer lecithin products antiseptic febrifuge products well painkillers hyperol kalmopyrin tonogen continue use constant janssen future janssen pharmaceuticals acquired distribution rights gedeon richters chemists gedeon richter chemical works budapest discovered brain enhancing drug gedeon richter signed contract danco laboratories market abortion pill mifepristone usa danco resolved contracting gedeon prior attempts find us distributor failed due politically volatile climate surrounding abortion country facing strong opposition us prolife groups gedeon decided end efforts place mifepristone us market may danco filed lawsuit gedeon lost million due gedeons breach may gedeon richter signed development supply agreement usbased company repros therapeutics produce july gedeon richter signed contract barr pharma production novartis lamisil barr paid gedeon richter royalty distributing product july april company constructed new manufacturing facility million october gedeon richter acquired private swiss biopharmaceutical company preglem chf million preglem focused treatment gynecological conditions stada arzneimittel ag gedeon richter signed license distribution agreement commercialize richter biosimilar pegfilgrastim europe according agreement stada receives nonexclusive distribution rights area geographical europe excluding russia richter retains rights distribute market biosimilar pegfilgrastim january william de gelsey resigned chairman board gedeon richter replaced former ceo erik bogsch served chief executive officer gedeon richter november new chief executive officer appointed gabor orban former fund manager government official bogsch deputy since de gelsey remains member april evestra signed collaboration partnership agreement gedeon february gedeon richter pantarhei bioscience signed license supply agreement commercialization novel combined oral september company started collaborating company mithra pharmaceuticals fr distribut contraceptive estelle europe richters atypical antipsychotic reagila containing active ingredient cariprazine awarded prize medicine year hungarian society experimental clinical pharmacology mft gedeon richter various subsidiaries different countries gedeon richter polska gedeon richter romania gedeon richter rus regional production subsidiaries richterthemis medicare india gedeon richter themis richterhelm biologics biotec germany mediplus nv curaçao gedeon richter mexico sapi de cv gedeon richter brasil importadora exportadora e distribuidora sa gedeon richter columbia sas international subsidiaries production companys chief governing body board directors boards chairman erik bogsch served chief executive officer since succeeded gábor orbán ceo november board members gábor gulácsi jános csák dr ilona hardy dr györgy bagdy csaba lantos anett pandurics bálint szécsényi prof dr szilveszter e vizi drkriszta companys governing bodies executive board supervisory board executive board led erik bogsch members gábor orbán gábor gulácsi istván greiner tibor horváth györgy thaler supervisory board led róbert jonathán bedros members attila chikán klára csikós kovácsné zsolt harmath éva kozsda december gedeon richter shareholder structure dividends approved shareholders gedeon richter eur million corporation two plants today headquarters budapest subsidiary dorog operating since company joint ventures india themis germany helm biotechnology plant debrecen gedeon richter recognized hungarian innovation foundation innovation grand prize development cariprazine antipsychotic drug used treatment schizophrenia bipolar gedeon richter gifted large sum international union pure applied chemistry iupac thereby establishing prize medicinal chemistry prize awarded every second year internationally recognized scientist normally medicinal chemist whose research publications made significant contribution practice medicinal chemistry prize initiated honor highlight central role medicinal chemistry improving human media related gedeon richter ltd wikimedia commons